• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

真性红细胞增多症患者淋巴细胞亚群的分布

Distribution of lymphocyte subpopulations in patients with polycythemia vera.

作者信息

Sanchez Carole, Le Treut Thérèse, Baier Céline, Sébahoun Gérard, Costello Régis T

机构信息

APHM, Laboratoire d'Hématologie, Hôpital Nord, Marseille, France; Aix-Marseille Univ, U1090, TAGC, 13008 Marseille, France.

APHM, Laboratoire d'Hématologie, Hôpital Nord, Marseille, France.

出版信息

Hum Immunol. 2015 Jun;76(6):414-6. doi: 10.1016/j.humimm.2015.03.021. Epub 2015 Apr 6.

DOI:10.1016/j.humimm.2015.03.021
PMID:25858863
Abstract

Polycythemia vera (PV) is a disease with slow development. Nonetheless, the immune response is unable to eliminate the uncontrolled proliferating hematopoietic cells, leading to treatment of patient by phlebotomy and/or cytotoxic drugs. In addition, a higher incidence of cancers is observed in PV patients, independently of treatment. These observations argue for an impaired immune response in PV. In order to investigate this hypothesis, we studied the distribution of lymphocyte subpopulations in PV, and showed a significant decrease in T, TCR γ/δ and B cells together with an increase in natural killer (NK) cells.

摘要

真性红细胞增多症(PV)是一种发展缓慢的疾病。尽管如此,免疫反应无法消除不受控制增殖的造血细胞,导致患者需通过放血和/或细胞毒性药物进行治疗。此外,无论是否接受治疗,PV患者的癌症发病率都较高。这些观察结果表明PV患者的免疫反应受损。为了研究这一假设,我们研究了PV患者淋巴细胞亚群的分布,结果显示T细胞、TCRγ/δ细胞和B细胞显著减少,而自然杀伤(NK)细胞增加。

相似文献

1
Distribution of lymphocyte subpopulations in patients with polycythemia vera.真性红细胞增多症患者淋巴细胞亚群的分布
Hum Immunol. 2015 Jun;76(6):414-6. doi: 10.1016/j.humimm.2015.03.021. Epub 2015 Apr 6.
2
Natural killer cells in patients with polycythemia vera.真性红细胞增多症患者的自然杀伤细胞
Hum Immunol. 2015 Sep;76(9):644-50. doi: 10.1016/j.humimm.2015.09.010. Epub 2015 Sep 25.
3
Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α.JAK2 阳性慢性骨髓增殖性肿瘤患者在接受α干扰素治疗期间循环 CD56bright 自然杀伤细胞的扩增。
Eur J Haematol. 2015 Mar;94(3):227-34. doi: 10.1111/ejh.12420. Epub 2014 Sep 24.
4
Interferon-α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F-positive essential thrombocythemia and polycythemia vera.干扰素-α可使JAK2V617F阳性原发性血小板增多症和真性红细胞增多症患者的循环调节性T细胞、自然杀伤细胞亚群及树突状细胞发生显著改变。
Eur J Haematol. 2016 Jul;97(1):83-92. doi: 10.1111/ejh.12687. Epub 2015 Nov 26.
5
Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.儿童真性红细胞增多症和原发性血小板增多症中骨髓增殖性疾病的标志物。
J Clin Oncol. 2007 Mar 20;25(9):1048-53. doi: 10.1200/JCO.2006.08.6884.
6
Quantitative abnormalities of peripheral blood distinct T, B, and natural killer cell subsets and clinical findings in obstetric antiphospholipid syndrome.产科抗磷脂综合征中外周血不同T、B和自然杀伤细胞亚群的定量异常及临床发现。
J Rheumatol. 2009 Jun;36(6):1217-25. doi: 10.3899/jrheum.081079. Epub 2009 Mar 30.
7
Frequency of Janus associated kinase 2 (V617F) mutation in patients of polycythemia vera.真性红细胞增多症患者中Janus相关激酶2(V617F)突变的频率
J Coll Physicians Surg Pak. 2012 Feb;22(2):80-3.
8
Distinctive CD8 T cell and MHC class I signatures in polycythemia vera patients.真性红细胞增多症患者中独特的 CD8 T 细胞和 MHC Ⅰ类分子特征。
Ann Hematol. 2018 Sep;97(9):1563-1575. doi: 10.1007/s00277-018-3332-7. Epub 2018 May 22.
9
Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera.JAK2V617F突变在鉴别真性红细胞增多症与特发性红细胞增多症中的应用价值。
Leuk Res. 2007 Jan;31(1):97-101. doi: 10.1016/j.leukres.2006.02.027. Epub 2006 Apr 18.
10
[The feature of T cell clonality with polycythemia vera].[真性红细胞增多症的T细胞克隆性特征]
Zhonghua Xue Ye Xue Za Zhi. 1999 Nov;20(11):570-2.

引用本文的文献

1
Neutrophil-to-Lymphocyte ratio as surrogate for JAK2 suppression and event-free survival in polycythemia vera.中性粒细胞与淋巴细胞比值作为真性红细胞增多症中JAK2抑制和无事件生存期的替代指标。
Blood Cancer J. 2025 Aug 6;15(1):132. doi: 10.1038/s41408-025-01317-6.
2
JAK2 impairs lymphoid differentiation in myeloproliferative neoplasms.JAK2损害骨髓增殖性肿瘤中的淋巴细胞分化。
Leukemia. 2024 Nov;38(11):2487-2491. doi: 10.1038/s41375-024-02388-3. Epub 2024 Sep 7.
3
Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms.
JAK2V617F 骨髓增殖性肿瘤中 NK 细胞亚群分布和功能改变导致肿瘤监视受损。
Front Immunol. 2022 Sep 23;13:768592. doi: 10.3389/fimmu.2022.768592. eCollection 2022.